Psychosis Market Forecast: How Big Will It Be by 2030?
Uncover key drivers, emerging technologies, and competitive movements shaping the psychosis market from 2026–2035 with trusted insights from The Business Research Company
Starting from its 2026 valuation, what market size is the Psychosis Market expected to reach by 2030?
The psychosis market has demonstrated substantial growth in recent years. It is anticipated to increase from $10.46 billion in 2025 to $11.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.8%. Historically, this expansion has been driven by the increasing diagnosis of schizophrenia and related disorders, the expansion of hospital-based psychiatric care, the wider use of antipsychotic medications, growing mental health awareness, and the availability of specialized mental health clinics.
The psychosis market is expected to experience significant growth in the coming years, reaching $13.7 billion in 2030 with a compound annual growth rate (CAGR) of 5.5%. This growth during the forecast period can be attributed to increased investment in the development of novel antipsychotic drugs, a rising focus on managing psychosis at early stages, the expansion of community-based mental health services, the increasing adoption of digital therapeutics, and a growing demand for long-term disease management. Major trends anticipated in the forecast period include the expanding use of long-acting injectable antipsychotics, a rising uptake of early intervention programs, a growing emphasis on integrated care models, the proliferation of digital monitoring tools for psychosis, and an enhanced focus on personalized treatment plans.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp
What Drivers Are Driving Adoption Within The Psychosis Market?
The rising incidence of mental health conditions is anticipated to drive expansion in the psychosis market moving forward. These conditions encompass disorders affecting an individual’s mood, thought processes, conduct, and general psychological well-being. The surge in mental health issues stems from elevated stress levels, shifts in lifestyle, social detachment, financial strains, and genetic factors. Psychosis treatment aids individuals experiencing mental health problems via prompt diagnosis, medical strategies, and tailored therapies, which boosts the consumption of antipsychotic drugs and various therapeutic approaches. As an illustration, the American Psychiatric Association, a professional US organization for psychiatrists and those in training, reported in May 2024 that 43% of adults experienced heightened anxiety levels compared to the preceding year, an increase from 37% in 2023 and 32% in 2022. Consequently, the rise in mental health conditions is propelling the expansion of the psychosis market.
What Segments Are Included Within The Psychosis Market?
The psychosis market covered in this report is segmented –
1) By Product: Tablet, Capsule, Injection
2) By Disease Type: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Disease Types
3) By Distribution Channel: Online, Offline
4) By End-User: Hospitals, Healthcare Clinics, Speciality Clinics, Other End-Users
Subsegments:
1) By Tablet: Antipsychotic Tablets, Mood Stabilizer Tablets
2) By Capsule: Antipsychotic Capsules, Antidepressant Capsules
3) By Injection: Long-acting Injectable Antipsychotics, Short-acting Injectable Antipsychotics
How Are Emerging Trends Affecting The Progression Of The Psychosis Market?
Organizations operating in the psychosis market are focusing on developing advanced patient feedback and data collection initiatives to enhance service design, inform policy decisions, and improve recovery-oriented care. These patient-voice initiatives enable individuals with firsthand experience and their families to directly share their needs, challenges, and outcomes through structured surveys and research, thereby supporting data-driven advocacy and more effective system reforms. For instance, in November 2025, Shine, an Ireland-based national mental health organization, in collaboration with Mental Health Reform, an Ireland coalition on mental health, and the HSE National Clinical Programme for Early Intervention in Psychosis (EIP), launched the 2025 National Survey of the Experiences of People Living with Psychosis. This initiative gathers firsthand insights from people with psychosis and their families to identify real-world experiences in accessing care, highlight systemic gaps and stigma, and guide improvements in national policy, investment in specialist early intervention services, and expansion of community-based and crisis support options.
Who Are The Prominent Global Companies Shaping The Psychosis Market Landscape?
Major companies operating in the psychosis market are Pfizer Inc., Johnson And Johnson, AbbVie Inc., Bristol Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Dr Reddys Laboratories Ltd., Lundbeck AS, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals SpA, BioXcel Therapeutics, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Zydus Lifesciences Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report
Which Geographic Areas Are Emerging As Strong Markets For The Psychosis Market?
North America was the largest region in the psychosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Psychosis Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=21266&type=smp
Browse Through More Reports Similar to the Global Psychosis Market 2026, By The Business Research Company
Mental Health Market Report 2026
https://www.thebusinessresearchcompany.com/report/mental-health-global-market-report
Psychiatrists Market 2026
https://www.thebusinessresearchcompany.com/report/psychiatrists-market
Oncologists Market Report 2026
https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
